BRIEF-SSY Group Obtains China FDA Approvals For Drug Production For Hemofiltration Replacement Fluid
Reuters Staff
1 Min Read
March 22 (Reuters) - SSY Group Ltd:
* OBTAINED APPROVALS FOR DRUG PRODUCTION AND REGISTRATION FOR HEMOFILTRATION REPLACEMENT FLUID FROM CHINA FDA Source text for Eikon: Further company coverage: